
Pomalid 2mg capsule
Salt Composition: Pomalidomide
Expiry Date: 01/2028
Inclusive of all taxes
21 Capsule(s) In A Bottle

Pomalid 2mg capsule
21 Capsule(s) In A Bottle
Pomalidomide
Salt Composition
Pomalidomide
Storage
Below 25°C
Expiry Date
01/2028
Marketer
Natco
Brand
pomalid

Pomalyst 4mg capsule
100 capsule
Pomalidomide
Salt Composition
Pomalidomide
Storage
Below 25°C
Expiry Date
01/2028
Marketer
Celgene
Brand
pomalyst
5966.png&w=1920&q=75)
MAGIC DEALS
Enquire
Apply Promo Code
Available CouponsPomalid 2mg capsule
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Lung Cancer
Description
Pomalid 2mg Capsule is an anticancer medicine with active ingredient Pomalidomide. It is prescribed to treat multiple myeloma.
It is used in the combination with some other medicine like dexamethasone but requires strict contraception due to high birth defect risk. This medicine is a powerful immunomodulatory anti-cancer drug that works by helping the bone marrow to produce normal blood cells and by killing abnormal cells by boosting the immune system.
It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.
Uses
- Multiple myeloma
Side Effects
The human body reacts differently to Pomalid 2mg Capsule. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.
Some of the common side effects of Capsule are mentioned below:
- Fatigue
- Fever
- Nausea
- Constipation
- Breathing problems
- Bone pain
- Muscle cramp
- Diarrhea
- Cough
- Decreased appetite
How To Use
- Take Pomalid 2mg Capsule in exact dose as prescribed by the doctor. The typical dose of this capsule varies with age and overall health factor of the patient. It can be taken with or without food but at a fixed time each day to get better results.
- It should be swallowed as a whole with water without crushing, chewing, or opening the capsule. Don't miss a dose or overdose the medicine.
How It Works
- Pomalid 2mg Capsule is an anticancer medicine with active ingredient Pomalidomide that is a powerful immunomodulatory anti-cancer drug. It works by by boosting the immune system, stopping new blood vessel formation (angiogenesis), and killing cancer cells directly.
- This medicine helps the bone marrow to produce normal blood cells and kill abnormal cells.
Safety Advice
FAQs
Pomalid 2mg Capsule is an anti-cancer medication used in the treatment of multiple myeloma.
References
Dimopoulos, M. A., Terpos, E., Boccadoro, M., Delimpasi, S., Beksac, M., Katodritou, E., ... &Zweegman, S. (2021). Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial. The Lancet Oncology , 22 (6), 801-812.
Ríos-Tamayo, R., Martín-García, A., Alarcón-Payer, C., Sánchez-Rodríguez, D., de la Guardia, A. M. D. V. D., García Collado, C. G., ... & Cabeza Barrera, J. (2017). Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy. Drug design, development and therapy , 2399-2408.
Dimopoulos, M. A., Beksac, M., Pour, L., Delimpasi, S., Vorobyev, V., Quach, H., ... & Trudel, S. (2024). Belantamabmafodotin, pomalidomide, and dexamethasone in multiple myeloma. New England Journal of Medicine , 391 (5), 408-421.
Fouquet, G., Bories, C., Guidez, S., Renaud, L., Herbaux, C., Javed, S., ... & Leleu, X. (2014). Pomalidomide for multiple myeloma. Expert Review of Hematology , 7 (6), 719-731.
Chanan-Khan, A. A., Swaika, A., Paulus, A., Kumar, S. K., Mikhael, J. R., Rajkumar, S. V., ... & Lacy, M. Q. (2013). Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma. Blood cancer journal , 3 (9), e143-e143.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)